SCHEMBL3479736

SCHEMBL3479736

CN1CCN(c2ccc3ccccc3c2)c2ccc(-c3ncns3)cc2C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 3/20 0.41
SCN9A Q15858 1/20 0.41
MET P08581 1/20 0.35
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34
XBP1 P17861 1/20 0.34
RAB9A P51151 1/20 0.34
KLF5 Q13887 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HTR6 P50406 5/20 0.33
HTR1A P08908 3/20 0.33
HTR2A P28223 3/20 0.33
DRD2 P14416 2/20 0.33
HTR7 P34969 2/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
TERT O14746 1/20 0.32
DRD3 P35462 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479711 0.88 SCN9A (0.42) SCN9AKDM4EMAPTTERTMAP4K1
SCHEMBL3229921 0.84 HTR3A (0.42) HTR3ASCN9AMETKDM4ENPC1
SCHEMBL3227917 0.84 SCN9A (0.40) SCN9AKDM4EMAPTTERT
SCHEMBL3479738 0.84 SCN9A (0.43) SCN9AKDM4EMAPTTERTHRH4
SCHEMBL3479957 0.84 SCN9A (0.41) SCN9AKDM4ENPC1MAPTRAB9A
SCHEMBL3229546 0.82 SCN9A (0.39) SCN9AKDM4EMAPTTERTHRH4
SCHEMBL3479598 0.82 HTR3A (0.46) HTR3ASCN9AMETKDM4ENPC1
SCHEMBL3232390 0.82 HTR3A (0.41) HTR3ASCN9AMETKDM4ENPC1
SCHEMBL3479750 0.81 HTR3A (0.45) HTR3ASCN9AMETKDM4ENPC1
SCHEMBL3220973 0.80 SCN9A (0.49) HTR3ASCN9AMETKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D HTR3A 30/4885SCN9A 795/4885MET 3840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.